These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7614179)

  • 1. Fluconazole response patterns in HIV-infected patients with oropharyngeal candidiasis.
    Diz Dios PD; Alvarez Alvarez J; Fernández Feijoo J; Castro Ferreiro M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Feb; 79(2):170-4. PubMed ID: 7614179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.
    Barchiesi F; Arzeni D; Del Prete MS; Sinicco A; Falconi Di Francesco L; Pasticci MB; Lamura L; Nuzzo MM; Burzacchini F; Coppola S; Chiodo F; Scalise G
    J Antimicrob Chemother; 1998 May; 41(5):541-8. PubMed ID: 9630407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oropharyngeal yeast flora and fluconazole resistance in HIV-infected patients receiving long-term continuous versus intermittent fluconazole therapy.
    Heald AE; Cox GM; Schell WA; Bartlett JA; Perfect JR
    AIDS; 1996 Mar; 10(3):263-8. PubMed ID: 8882665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patients.
    Martins MD; Lozano-Chiu M; Rex JH
    Clin Infect Dis; 1998 Nov; 27(5):1291-4. PubMed ID: 9827284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the E test for fluconazole susceptibility testing of Candida albicans isolates from oropharyngeal candidiasis.
    Dannaoui E; Colin S; Pichot J; Piens MA
    Eur J Clin Microbiol Infect Dis; 1997 Mar; 16(3):228-32. PubMed ID: 9131326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
    Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
    Saag MS; Fessel WJ; Kaufman CA; Merrill KW; Ward DJ; Moskovitz BL; Thomas C; Oleka N; Guarnieri JA; Lee J; Brenner-Gati L; Klausner M
    AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1413-7. PubMed ID: 10555103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between in vitro resistance to fluconazole and clinical outcome of oropharyngeal candidiasis in HIV-infected patients.
    Quereda C; Polanco AM; Giner C; Sánchez-Sousa A; Pereira E; Navas E; Fortún J; Guerrero A; Baquero F
    Eur J Clin Microbiol Infect Dis; 1996 Jan; 15(1):30-7. PubMed ID: 8641300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China.
    Jiang L; Yong X; Li R; Peng Y; Liu W; Qin Q; Zhang L; Liu Z; Liang H; Tao R
    J Oral Pathol Med; 2014 Oct; 43(9):696-703. PubMed ID: 24931443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oropharyngeal candidiasis resistant to fluconazole in patients infected by HIV].
    Drobacheff C; Manteaux A; Millon L; Reboux G; Barale T; Laurent R
    Ann Dermatol Venereol; 1996; 123(2):85-9. PubMed ID: 8761757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between fluconazole dosage regimens and the emergence of fluconazole-resistant Candida albicans.
    Goetz MB
    AIDS; 1996 Mar; 10(3):335-6. PubMed ID: 8882674
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluconazole resistant oral candidiasis in HIV-infected patients.
    Tumbarello M; Tacconelli E; Caldarola G; Morace G; Cauda R; Ortona L
    Oral Dis; 1997 May; 3 Suppl 1():S110-2. PubMed ID: 9456668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed oropharyngeal candidiasis due to Candida albicans and non-albicans Candida strains in HIV-infected patients.
    Dronda F; Alonso-Sanz M; Laguna F; Chaves F; Martínez-Suárez JV; Rodríguez-Tudela JL; González-López A; Valencia E
    Eur J Clin Microbiol Infect Dis; 1996 Jun; 15(6):446-52. PubMed ID: 8839637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis.
    Johnson EM; Warnock DW; Luker J; Porter SR; Scully C
    J Antimicrob Chemother; 1995 Jan; 35(1):103-14. PubMed ID: 7768758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral Candida albicans isolates with reduced susceptibility to fluconazole in Swedish HIV-infected patients.
    Chryssanthou E; Torssander J; Petrini B
    Scand J Infect Dis; 1995; 27(4):391-5. PubMed ID: 8658076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans.
    Laguna F; Rodríguez-Tudela JL; Martínez-Súarez JV; Polo R; Valencia E; Díaz-Guerra TM; Dronda F; Pulido F
    Clin Infect Dis; 1997 Feb; 24(2):124-30. PubMed ID: 9114134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients.
    Troillet N; Durussel C; Bille J; Glauser MP; Chave JP
    Eur J Clin Microbiol Infect Dis; 1993 Dec; 12(12):911-5. PubMed ID: 8187785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between fluconazole sensitivity of Candida albicans isolates from HIV positive patients and serotype, adherence and CD4+ lymphocyte count.
    Imbert-Bernard C; Valentin A; Reynes J; Mallié M; Bastide JM
    Eur J Clin Microbiol Infect Dis; 1994 Sep; 13(9):711-6. PubMed ID: 7843175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluconazole-resistant Candida species in the oral flora of fluconazole-exposed HIV-positive patients.
    Hunter KD; Gibson J; Lockhart P; Pithie A; Bagg J
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 May; 85(5):558-64. PubMed ID: 9619674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients.
    Vuffray A; Durussel C; Boerlin P; Boerlin-Petzold F; Bille J; Glauser MP; Chave JP
    AIDS; 1994 May; 8(5):708-9. PubMed ID: 8060555
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.